Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma

There are no effective medical treatments for WHO grade III (anaplastic) meningioma. Patients with this high-grade malignancy have a median survival of less than two years. Therapeutics that modulate the mechanisms that inhibit local immune responses in the tumor microenvironment are showing signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Ziming, Abedalthagafi, Malak, Aizer, Ayal A., McHenry, Allison R., Sun, Heather H., Bray, Mark-Anthony, Viramontes, Omar, Machaidze, Revaz, Brastianos, Priscilla K., Reardon, David A., Dunn, Ian F., Freeman, Gordon J., Ligon, Keith L., Carpenter, Anne E., Alexander, Brian M., Agar, Nathalie Y., Rodig, Scott J., Bradshaw, Elizabeth M., Santagata, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467109/
https://www.ncbi.nlm.nih.gov/pubmed/25609200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467109/
https://www.ncbi.nlm.nih.gov/pubmed/25609200

Ejemplares similares